Drug intelligence / Profile preview

alpha,beta-methyleneadenosine 5'-triphosphate

Development stage
Unknown
Modality
Small Molecules
01

Overview

Alpha,beta-methyleneadenosine 5'-triphosphate is a synthetic nucleoside triphosphate analog of adenosine triphosphate (ATP) in which the bridging oxygen atom between the α and β phosphate groups is replaced by a methylene group. This modification makes it resistant to enzymatic hydrolysis. It acts as an agonist at P2X purinoceptors, particularly P2X1 and P2X3 subtypes, where it is more potent than ATP itself. It has much lower potency at other P2X (such as P2X2 and P2X4–7) and at P2Y receptors. Persistent activation of these receptors can lead to desensitization, resulting in antagonist-like effects. The compound is widely used in research to study purinergic signaling mechanisms and receptor pharmacology[6][7]. It also weakly inhibits adenylate cyclase activity.

Other names
α,β-Methyleneadenosine 5'-triphosphatea,b-Methylene ATPATP, a,b-methylene-Alpha,Beta Methylene ATPadenosine 5'-[alpha,beta-methylene]triphosphate
02

Targets

AC (Adenylyl cyclase family)P2X3 (P2X purinoceptor 3)P2RX1 (Purinergic receptor P2X 1)

Beyond the preview

Go deeper on alpha,beta-methyleneadenosine 5'-triphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha,beta-methyleneadenosine 5'-triphosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call